Literature DB >> 34074623

Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.

Anna M Chiarella1, Yun K Ryu2, Gulam A Manji3, Anil K Rustgi4.   

Abstract

ATP hydrolysis and downstream signaling pathways in the extracellular space have a major impact upon tumor progression and metastasis. The complexity and interdependence of various cell types in the extracellular space have been increasingly appreciated in recent years. With increased awareness of the importance of this signaling pathway in the pathogenic development and progression of malignancies, there has been attention to therapeutic strategies targeting extracellular adenosine metabolism and signaling. This review summarizes the molecular and physiologic roles of extracellular ATP and adenosine in normal and disease states, and potential therapeutic applications.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD39; CD73; cancer; extracellular ATP; extracellular adenosine; purinergic signaling

Mesh:

Substances:

Year:  2021        PMID: 34074623     DOI: 10.1016/j.trecan.2021.04.008

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  10 in total

Review 1.  The circadian regulation of extracellular ATP.

Authors:  Xin Wang; Yu-Ting Dong; Xiu-Ming Hu; Ji-Zhou Zhang; Nan-Rui Shi; Yan-Qin Zuo; Xu Wang
Journal:  Purinergic Signal       Date:  2022-08-08       Impact factor: 3.950

2.  Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients.

Authors:  Chunnan Liu; Zhaopei Liu; Kaifeng Jin; Han Zeng; Fei Shao; Yuan Chang; Yiwei Wang; Le Xu; Zewei Wang; Yu Zhu; Weijuan Zhang
Journal:  Br J Cancer       Date:  2022-08-23       Impact factor: 9.075

3.  Effects of Exogenous ATP on Melanoma Growth and Tumor Metabolism in C57BL/6 Mice.

Authors:  Yali Lei; Xu Zhou; Yang Zhao; Jianfa Zhang
Journal:  Comp Med       Date:  2022-04-11       Impact factor: 1.565

4.  Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling.

Authors:  Davide Ferrari; Stefania Gessi; Stefania Merighi; Manuela Nigro; Alessia Travagli; Jorge S Burns
Journal:  Front Cell Dev Biol       Date:  2022-05-04

Review 5.  Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.

Authors:  Huai-Liang Wu; Yue Gong; Peng Ji; Yi-Fan Xie; Yi-Zhou Jiang; Guang-Yu Liu
Journal:  J Hematol Oncol       Date:  2022-04-27       Impact factor: 23.168

Review 6.  Structure-activity features of purines and their receptors: implications in cell physiopathology.

Authors:  Mauricio Díaz-Muñoz; Rolando Hernández-Muñoz; Armando Butanda-Ochoa
Journal:  Mol Biomed       Date:  2022-01-26

Review 7.  Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?

Authors:  Jana Kotulová; Marián Hajdúch; Petr Džubák
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 8.  Influence of the Metabolism on Myeloid Cell Functions in Cancers: Clinical Perspectives.

Authors:  Thomas Boyer; Céline Blaye; Nicolas Larmonier; Charlotte Domblides
Journal:  Cells       Date:  2022-02-05       Impact factor: 6.600

9.  Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System.

Authors:  Long Wu; Wei Xie; Yang Li; Qiankun Ni; Peter Timashev; Meng Lyu; Ligang Xia; Yuan Zhang; Lingrong Liu; Yufeng Yuan; Xing-Jie Liang; Qiqing Zhang
Journal:  Adv Sci (Weinh)       Date:  2022-04-09       Impact factor: 17.521

10.  CD73 facilitates invadopodia formation and boosts malignancy of head and neck squamous cell carcinoma via the MAPK signaling pathway.

Authors:  Feifei Xue; Tianxiao Wang; Hao Shi; Hongjie Feng; Guanying Feng; Ruixia Wang; Yao Yao; Hua Yuan
Journal:  Cancer Sci       Date:  2022-06-16       Impact factor: 6.518

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.